非人灵长类动物实验表明：艾滋病候选疫苗可单针诱导中和抗体

Core Viewpoint - A new candidate vaccine for HIV developed by scientists at the Wistar Institute has shown significant results in non-human primate trials, requiring only a single injection to induce neutralizing antibodies against the HIV virus, which could greatly reduce the vaccination schedule compared to previous vaccines that required seven to ten doses [1] Group 1 - The new vaccine demonstrates the potential to shorten the vaccination timeline, making it easier to promote HIV vaccines globally [1] - The research findings have been published in the latest issue of the journal Nature Immunology, highlighting the scientific community's interest in this breakthrough [1]